Paper1759136
Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.
Havu N and 2 others. Scand J Gastroenterol Suppl, 1991. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease. Papers, record 1759136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1759136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enterochromaffin Cells | Major topic |
| Gastric Mucosa | Major topic |
| Gastritis | Major topic |
| Stomach Ulcer | Major topic |
| Adult | |
| Aged | |
| Chronic Disease | |
| Female | |
| Gastritis, Atrophic | |
| Humans | |
| Hyperplasia | |
| Male | |
| Middle Aged |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25698559 | Hypergastrinemia. | Gastroenterol Rep (Oxf) | 2015 | https://conductscience.org/library/papers/25698559 | PubMed |
| 24714139 | Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells. | Ann Gastroenterol | 2012 | https://conductscience.org/library/papers/24714139 | PubMed |
| 16905689 | Proton pump inhibitors and gastric neoplasia. | Gut | 2006 | https://conductscience.org/library/papers/16905689 | PubMed |
| 8432447 | Gastroscopic follow up of pernicious anaemia patients. | Gut | 1993 | https://conductscience.org/library/papers/8432447 | PubMed |
| 8200548 | Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. | Gut | 1994 | https://conductscience.org/library/papers/8200548 | PubMed |
| 8136088 | Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders. | Drug Saf | 1994 | https://conductscience.org/library/papers/8136088 | PubMed |
| 8093871 | Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8093871 | PubMed |
| 7859587 | Pathophysiological effects of long-term acid suppression in man. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7859587 | PubMed |
| 7859584 | Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7859584 | PubMed |
| 7859582 | Optimizing acid suppression for treatment of acid-related diseases. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7859582 | PubMed |
| 7766337 | A comparative overview of the adverse effects of antiulcer drugs. | Drug Saf | 1995 | https://conductscience.org/library/papers/7766337 | PubMed |
| 7601011 | Pharmacological management of gastro-oesophageal reflux disease. | Drugs | 1995 | https://conductscience.org/library/papers/7601011 | PubMed |
| 7502528 | The consequences of hypergastrinemia. | Yale J Biol Med | 1994 | https://conductscience.org/library/papers/7502528 | PubMed |
| 1932982 | Omeprazole. | BMJ | 1991 | https://conductscience.org/library/papers/1932982 | PubMed |
| 1718683 | Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. | Drugs | 1991 | https://conductscience.org/library/papers/1718683 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1759136
GET https://conductscience.org/api/papers/v1/1759136/authors